Summary of MERIDIAN BIOSCIENCE INC

Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) On June 12, 2012, Meridian Bioscience, Inc. (the "Company") entered into an Amended and Restated Employment Agreement (the "Employment Agreement") with John A. Kraeutler, Chief Executive Officer of the Company, which amended and restated an employment agreement with Mr. Kraeutler dated February 15, 2001, as previously amended on December 29, 2008. In connection with the Employment Agreement, on June 12, 2012, the Company also entered into a Supplemental Benefit Agreement (the "Supplemental Agreement" and, collectively with the Employment Agreement, the "Agreements") with Mr. Kraeutler, which amended and restated a salary continuation agreement dated January 19, 1995, as previously amended on April 24, 2001, December 29, 2008 and August 3, 2011. The purpose of the Agreements is to secure Mr. Kraeutler's employment by the Company through the Employment Agreement's initial term ending September 30, 2014 and provide optional additional one year terms.

Subject to certain adjustments related to termination due to death, disability, cause or good reason (as defined therein), the Agreements provide that Mr. Kraeutler will be entitled to:

Employment Agreement
· Annual base salary of no less than $562,000

· Annual bonus as established by the Board of Directors

· One-time grant of 25,000 performance-based restricted stock units under the Company's 2012 Stock Incentive Plan, to vest in full on September 30, 2014 subject to attainment of performance targets

· Eligibility to receive additional grants of stock-based compensation under the Company's 2012 Stock Incentive Plan

· In the event of (i) termination by the Company without cause, (ii) termination by Mr. Kraeutler for good reason or (iii) termination by the Company other than for cause or by Mr. Kraeutler without good reason, 90 days prior to or within thirty-six (36) months following a change of control, eligibility to receive a lump sum payment equal to three (3) times the sum of average annual base salary and average annual bonus amounts received for the immediately preceding thirty-six (36) months, and continued participation in all Company benefit programs in which participating as of termination for a period equal to the lesser of three (3) years or until the date employed at another location

· Re-affirmation by the Company and Mr. Kraeutler of the terms of the Non-Competition and Confidentiality Agreement dated October 8, 1992

Supplemental Agreement
· Eligibility to receive post-retirement payments totaling $1,200,000, payable in one hundred twenty (120) monthly payments of $10,000, in the event of a qualified retirement from service (as defined therein); total payments reduced to $600,000, payable in one hundred twenty (120) monthly payments of $5,000, in the event of a non-qualified retirement from service (as defined therein)

· Lifetime insurance benefits including Medicare health insurance supplement premiums and comprehensive long-term care insurance premiums

The foregoing summary of the Agreements does not purport to be complete and is subject to, and qualified in its entirety by, the full text of such documents, copies of which are filed as Exhibit 10.17 and Exhibit 10.18 to this Current Report on Form 8-K and are incorporated herein by reference.